Health-monitoring device
First Claim
1. A health-monitoring device, comprising:
- a housing;
a test port in communication with the housing, wherein the test port is configured to receive a test strip;
a processor in communication with the housing and configured to determine a plurality of blood glucose concentrations over a plurality of days from blood samples deposited on test strips received at the test port;
a storage unit in communication with the housing and comprising one ore more programs executable by the processor fordetermining the concentration of glucose in the blood samples deposited on the test strips, anddetecting a pattern in the subject'"'"'s blood glucose levels determined from the blood samples deposited on the test strips over a same period of time over a plurality of days,wherein the period of time is a sub-period of time within a day; and
a display coupled to the housing and configured to output information comprising the determined blood glucose concentration,an indication of the detected pattern in the subject'"'"'s blood glucose levels over a same period of time over a plurality of days, andan indication of impending hypoglycemia or hyperglycemia in the subject based on the detected pattern in the subject'"'"'s blood glucose levels over a same period of time over a plurality of days.
2 Assignments
0 Petitions
Accused Products
Abstract
A health-monitoring device assesses the health of a user based on levels of two analytes in a biological fluid. A first analyte that is utilized to assess a user'"'"'s health is a fat metabolism analyte, such as ketones, free fatty acids and glycerol, which is indicative of fat metabolism. A second analyte that is utilized is a glucose metabolism analyte, such as glucose. The levels of the two analytes may be used to assess insulin sensitivity, to detect both recent hypoglycemia and the cause of high glucose levels, and/or to guide therapeutic intervention. The dual analyte model may calculate a discrepancy between an actual insulin activity level and a theoretical insulin activity level. The dual analyte model of the present invention may be used to identify individuals at risk for metabolic syndrome, insulin resistance and non-insulin dependent diabetes, and allows monitoring of the progression of those disease states, as well as progress made by therapeutic interventions.
21 Citations
41 Claims
-
1. A health-monitoring device, comprising:
-
a housing; a test port in communication with the housing, wherein the test port is configured to receive a test strip; a processor in communication with the housing and configured to determine a plurality of blood glucose concentrations over a plurality of days from blood samples deposited on test strips received at the test port; a storage unit in communication with the housing and comprising one ore more programs executable by the processor for determining the concentration of glucose in the blood samples deposited on the test strips, and detecting a pattern in the subject'"'"'s blood glucose levels determined from the blood samples deposited on the test strips over a same period of time over a plurality of days, wherein the period of time is a sub-period of time within a day; and a display coupled to the housing and configured to output information comprising the determined blood glucose concentration, an indication of the detected pattern in the subject'"'"'s blood glucose levels over a same period of time over a plurality of days, and an indication of impending hypoglycemia or hyperglycemia in the subject based on the detected pattern in the subject'"'"'s blood glucose levels over a same period of time over a plurality of days. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)
-
Specification